Long-acting injections to treat HIV
View More
Unitaid-funded projects develop innovative medicines, diagnostic tools and public health techniques and link them quickly, and at affordable prices, to those most in need.
Our grant projects apply the best that science has to offer to the fight against HIV and co-infections, tuberculosis and malaria in lower-resource countries.
Grant focus
To transform oral HIV treatment into a long-acting injectable
Grantees
University of Washington
Status
Current
Amount
US$ 6,962,027
Disease
HIV and Co-Infection
View More
Grant focus
To develop long-acting formulations of key medicines and create a market for them
Grantees
University of Liverpool
Status
Current
Amount
US$ 32,004,459
Disease
Hepatitis C, HIV and Co-Infection, Malaria, Tuberculosis
View More
Grant focus
Bringing secondary prevention of cervical cancer to scale in low- and middle-income countries
Grantees
Expertise France
Status
Current
Amount
US$ 24,322,600
Disease
Cervical Cancer, HIV and Co-Infection
View More
Grant focus
Reducing transmission and improving access to hepatitis C treatment for key populations
Grantees
Frontline AIDS
Status
Current
Amount
US$ 9,218,918
Disease
Hepatitis C, HIV and Co-Infection
View More
Grantees
Médecins du Monde
Status
Current
Amount
US$ 9,363,092
Disease
Hepatitis C, HIV and Co-Infection
View More
Grantees
PATH
Status
Current
Amount
US$ 12,810,525
Disease
Hepatitis C, HIV and Co-Infection
View More
Grant focus
To create affordable solutions for preventing cervical cancer
Grantees
Clinton Health Access Initiative (CHAI)
Status
Current
Amount
US$ 41,018,136
Disease
Cervical Cancer, HIV and Co-Infection
View More
Grant focus
Catalysing access to an affordable advanced HIV disease package of care that can be scaled up by countries and funding partners
Grantees
Clinton Health Access Initiative (CHAI)
Status
Current
Amount
US$ 20,000,000*
Disease
HIV and Co-Infection
View More